Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acute Myeloid Leukemia (AML) Clinical Trial in Vitoria Alava
NCT02927262 | Phase 2 | Interventional

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 98 Participants

The purpose of this study was to compare relapse-free survival (RFS) between participants with FMS-like tyrosine kinase 3 (FLT3) / internal tandem duplication (ITD) acute myeloid leukemia (AML) in first complete remission (CR1) and who were randomized to receive gilteritinib or placebo beginning after completion of induction/consolidation chemotherapy for a two-year period.